INBP

$0.17+0.00%visit website

INTEGRATED BIOPHARMA INC

Market Cap

$5M

Live price × SEC shares (Sep 23, 2026)

Sector

Health Care

Industry

Pharmaceutical Preparations

Beta (raw)

0.48

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

0.1

TTM to Jun 2026 · revenue

P/B

0.3

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q1 FY2026 Sep 30, 2025	Q2 FY2026 Dec 31, 2025	Q3 FY2026 Mar 31, 2026	Q4 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	12,689	11,280	10,107	9,796	43,872
Cost of revenue	11,670	11,251	10,383	9,768	43,072
Gross profit	1,019	29	(276)	28	800
Selling, general & administrative	856	943	809	897	3,505
Operating income	163	(914)	(1,085)	(869)	(2,705)
Interest expense	(33.0)	(40.0)	(39.0)		12.0
Pretax income	196	(874)	(1,035)	(850)	(2,563)
Income tax	73	(112)	(198)	516	279
Net income	123	(762)	(837)	(1,366)	(2,842)
EPS (basic) ($)	0.00	(0.03)	(0.03)		(0.09)
EPS (diluted) ($)	0.00	(0.03)	(0.03)		(0.09)
Weighted avg. shares (basic)	31,060	31,060	31,060
Weighted avg. shares (diluted)	31,421	31,060	31,060

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-K filed Sep 25, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 60 more quarters, back to Sep 2010, with Tormere Pro.

Corporate Events (8-K)

9 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Sep 25, 2026 accepted 5:05 PM ET	2.02Earnings release	Document SEC ↗
Aug 20, 2026 accepted 3:27 PM ET	8.01Other events	Document SEC ↗
Jul 2, 2026 accepted 10:37 AM ET	1.01Material agreement1.02Agreement terminated	Document SEC ↗
May 8, 2026 accepted 4:33 PM ET	2.02Earnings release	Document SEC ↗
Apr 15, 2026 accepted 3:35 PM ET	8.01Other events	Document SEC ↗
Feb 18, 2026 accepted 4:23 PM ET	1.01Material agreement	Document SEC ↗
Feb 11, 2026 accepted 4:35 PM ET	2.02Earnings release	Document SEC ↗
Dec 1, 2025 accepted 5:16 PM ET	5.07Shareholder vote	Document SEC ↗
Nov 10, 2025 accepted 3:54 PM ET	2.02Earnings release	Document SEC ↗
Sep 23, 2025 accepted 3:42 PM ET	2.02Earnings release	Document SEC ↗